The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 17,439 |
| Deferred income taxes | 5,892 |
| Provision for credit losses | 556 |
| Depreciation and amortization | 15,320 |
| Amortization and accretion of premiums/discounts on investment securities | -771 |
| Amortization of operating lease right-of-use assets | 1,968 |
| Stock-based compensation cost | 2,699 |
| Purchase accounting accretion, net | -26,580 |
| Originations of loans held for sale | 429,788 |
| Proceeds on loans held for sale | 435,416 |
| Realized loss (gain) on mortgage loans sold | 8,964 |
| Realized loss (gain) on non-mortgage loans sold | 2,080 |
| Servicing rights capitalized upon sale of mortgage loans | -165 |
| (increase) in value of bank-owned life insurance | 1,063 |
| Realized loss (gain) on sale of premises and equipment | -530 |
| Realized loss (gain) on derivative instruments | 394 |
| Realized loss (gain) on sale of foreclosed assets | -74 |
| Realized loss (gain) on sale of investment securities | -68,403 |
| Realized loss (gain) on boli mortality | 0 |
| Change in fair value of mortgage servicing rights | -1,700 |
| Realized loss (gain) on servicing rights | 0 |
| Realized loss (gain) on sale of esop trustee line of business | 0 |
| Accrued interest receivable | 1,667 |
| Other assets | 11,287 |
| Accrued expenses and other liabilities | -1,249 |
| Net cash provided (used) by operating activities | 67,530 |
| Proceeds from sales of trading investment securities | 6,233 |
| Purchases of trading investment securities | 4,571 |
| Proceeds from sales or calls of investment securities available-for-sale | 396,417 |
| Proceeds from maturities of investment securities available-for-sale | 82,558 |
| Purchases of investment securities available-for-sale | 377,565 |
| Proceeds from calls of investment securities held-to-maturity | 381 |
| Proceeds from maturities and paydowns of investment securities held-to-maturity | 19,835 |
| Proceeds from sale of non-mortgage loans held for sale | 62,491 |
| Net (increase) decrease in loans | 96,386 |
| Purchases of fhlb stock | 146,149 |
| Sales of fhlb stock | 141,837 |
| Net cash received (paid) for business combinations | 0 |
| Purchases of boli | 2,211 |
| Proceeds from boli mortality claim | 0 |
| Purchases of premises and equipment | 8,699 |
| Proceeds from sales of foreclosed assets | 2,378 |
| Net cash provided (used) by investing activities | 76,550 |
| Net increase (decrease) in deposits | -186,407 |
| Net increase (decrease) in short-term borrowings with maturities of three months or less | 69,840 |
| Cash dividends paid on common stock | 20,823 |
| Repurchase of common stock | 737 |
| Net cash provided (used) by financing activities | -138,127 |
| Net change in cash and cash equivalents | 5,953 |
| Cash and cash equivalents at beginning of year | 61,239 |
| Cash and cash equivalents at end of year | 67,192 |
ALERUS FINANCIAL CORP (ALRS)
ALERUS FINANCIAL CORP (ALRS)